Therefore, setmelanotide is indicated in patients with genetic obesity due to either the defect in the pro-opiomelanocortin (POMC) gene, Leptin receptors (LEPR)gene, and the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene. Here, LEPR is linked to Genetic obesity.